MacDougall Creative 11/14/22 MacDougall Creative 11/14/22

OncoNano Medicine Announces New Preclinical Data for ON-BOARD™ Platform for Delivery of Bispecific T Cell Engagers and a Therapeutic Cytokine at SITC Annual Meeting

MacDougall Creative 11/14/22 MacDougall Creative 11/14/22

OncoNano Medicine Announces Pre-Clinical Data for Dual-Activating STING agonist at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

MacDougall Creative 10/5/22 MacDougall Creative 10/5/22

OncoNano Medicine to Present Data on Novel Development Candidates at the Society for Immunology of Cancer (SITC) Annual Meeting

MacDougall Creative 9/29/22 MacDougall Creative 9/29/22

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an adjunct to Cytoreductive Surgery of Peritoneal Carcinomatosis

MacDougall Creative 9/19/22 MacDougall Creative 9/19/22

OncoNano Medicine to Present at Cantor Fitzgerald Oncology & HemOnc Conference

MacDougall Creative 9/14/22 MacDougall Creative 9/14/22

OncoNano Medicine Announces Oral Presentation of Phase 2 Study Data at the World Molecular Imaging Congress 2022

MacDougall Creative 6/1/22 MacDougall Creative 6/1/22

OncoNano Medicine Appoints Kartik Krishnan, M.D., Ph.D., as Chief Medical Officer

MacDougall Creative 5/10/22 MacDougall Creative 5/10/22

OncoNano Medicine Announces the Appointment of Elina Lavit as Vice President, Business Development

MacDougall Creative 4/13/22 MacDougall Creative 4/13/22

OncoNano Medicine Announces Positive Preclinical Data for ONM-501 at AACR 2022 Annual Meeting

MacDougall Creative 4/12/22 MacDougall Creative 4/12/22

OncoNano Medicine Announces Positive Preclinical Data for Tumor Specific Delivery with the ON-BOARD Platform at AACR 2022 Annual Meeting

MacDougall Creative 3/11/22 MacDougall Creative 3/11/22

OncoNano Medicine to Present at the American Association for Cancer Research (AACR) Annual Meeting 2022

MacDougall Creative 12/17/21 MacDougall Creative 12/17/21

OncoNano Medicine Appoints Brett Giroir, M.D., to Board of Directors

MacDougall Creative 10/25/21 MacDougall Creative 10/25/21

$18.4 Million Equity Investment by the Cancer Prevention and Research Institute of Texas

MacDougall Creative 10/14/21 MacDougall Creative 10/14/21

Pegsitacianine Demonstrates Tumor-Agnostic Real-Time Surgical Imaging in Phase 2 Study

MacDougall Creative 10/8/21 MacDougall Creative 10/8/21

Positive Preclinical Data for ONM-501 at AACR Virtual Conference

MacDougall Creative 9/30/21 MacDougall Creative 9/30/21

Present at The American Association for Cancer Research Virtual Conference

MacDougall Creative 9/22/21 MacDougall Creative 9/22/21

Expanded Research Collaboration with UT Southwestern Medical Center

MacDougall Creative 9/20/21 MacDougall Creative 9/20/21

OncoNano Medicine to Present at The World Molecular Imaging Congress

MacDougall Creative 7/22/21 MacDougall Creative 7/22/21

OncoNano Medicine Raises ~$50 Million in Series B Financing

MacDougall Creative 7/19/21 MacDougall Creative 7/19/21

OncoNano Medicine to Present at the 2nd Annual LifeSci Partners Private Company Summer Symposium

Press Releases